145.84 USD
↘ 2.21 (1.49%)LIVE (AS OF 11:34 AM EST)
Merck & Co., Inc.
MRKNYSE • USD
Market: OPEN
Merck & Co., Inc. (MRK) trades at $145.84 per share. The technical outlook is "Buy" and the fundamental picture shows "Neutral". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 2/9 and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Nov 10, 2026.
Open?$146.61
High?$147.96
Low?$145.35
Prev. Close?$148.05
Volume?1.6M
Avg. Volume?9.8M
VWAP?$146.07
Rel. Volume?0.16x
Bid / Ask
Bid?$146.26 × 100
Ask?$146.30 × 100
Spread?$0.04
Midpoint?$146.28
Valuation & Ratios
Market Cap?365.0B
Shares Out?2.5B
Float?2.4B
Float %?97.9%
P/E Ratio?148.79
P/B Ratio?8.13
EPS?$1.00
Dividend?2.29%
Ex-Dividend?N/A
News
Profile
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. In cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 53% of the company's 2025 sales were generated from US human health (pharmaceuticals and vaccines).
Themes
Employees
75.0K
Market Cap
365.0B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
1949-04-20
Address
126 EAST LINCOLN AVENUE
RAHWAY, NJ 07065
Phone: 908-740-4000
RAHWAY, NJ 07065
Phone: 908-740-4000
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?12
Z-Score?91
Momentum?35
Short Sent.?84
Piotroski F-Score?2/9Weak
Altman Z-Score?3.93Safe
Confidence?59%Low
Short InterestLow
Short % of Float?1.10%Low
Short Interest?26.6M
Days to Cover?2.4
Free Float2.4B
Avg Daily Volume11.3M
Settlement Date2026-10-30
Financial Health
Current Ratio?1.35Adequate
Quick Ratio?1.14Adequate
Cash Ratio?0.33Low
Debt/Equity?1.20Moderate
ValuationRICHLY VALUEDvs 10 peers + S&P 500
Score44/100
P/E?148.8PRICEY▾
Peers11
S&P3
P/B?8.13HIGH▾
Peers70
S&P23
P/S?5.42FAIR▾
Peers82
S&P26
P/FCF?24.8FAIR▾
Peers70
S&P40
EV/EBITDA?30.2HIGH▾
Peers30
S&P10
EV/Sales?6.07HIGH▾
Peers82
S&P27
Returns & Efficiency
ROE?5.5%FAIR▾
Peers25
S&P20
ROA?1.8%WEAK▾
Peers11
S&P18
Cash Flow & Enterprise
FCF?$14.7B
Enterprise Value?$409.2B
Fundamentals ratios updated end of day